Delivery Order SPE2DR25D2012-SPE2DR26F1BSU
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,856.10 on December 17, 2025, for the supply of Adderall XR 20 mg capsules (100-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,592.02 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,431,067 units of Adderall XR 10 mg capsules. The $3,503.80 delivery order is part of a larger contract between Amerisourcebergen Drug Corp and DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has extensive experience...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Adderall XR 25 mg capsules (100-count units) with a contract ceiling value of $1,316.56. This competitively awarded, firm fixed-price delivery order was executed on November 12, 2025, with an ultimate completion date of November 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,114.59 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count) on December 10, 2025, with a completion date of December 11, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.64 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $5,587.61. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,721.12 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units). This competitive award, made on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,594.81 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 4, 2025, with completion expected by December 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BSUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,048.04 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Adderall XR 20 mg capsules (100-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 14, 2026, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle that serves as the primary procurement mechanism for pharmaceutical and medical supply deliveries supporting military healthcare programs globally through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs across the Department of Defense and veteran healthcare systems. The company maintains significant contract vehicles with both the DLA and Department of Veterans Affairs, demonstrating substantial capability to fulfill government pharmaceutical requirements across multiple therapeutic domains. This delivery order for a controlled pharmaceutical product reflects the company's continued role as a key supplier of essential medications to federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/12/26 |